Systematic reviews do not (yet) represent the 'gold standard' of evidence: A position paper.

Eur J Pain

Cochrane Pain, Palliative, and Supportive Care Review Groups, Oxford University Hospitals, Oxford, UK.

Published: March 2022

The low quality of included trials, insufficient rigour in review methodology, ignorance of key pain issues, small size, and over-optimistic judgements about the direction and magnitude of treatment effects all devalue systematic reviews, supposedly the 'gold standard' of evidence. Available evidence indicates that almost all systematic reviews in the published literature contain fatal flaws likely to make their conclusions incorrect and misleading. Only 3 in every 100 systematic reviews are deemed to have adequate methods and be clinically useful. Examples of research waste and questionable ethical standards abound: most trials have little hope of providing useful results, and systematic review of hopeless trials inspires no confidence. We argue that results of most systematic reviews should be dismissed. Forensically critical systematic reviews are essential tools to improve the quality of trials and should be encouraged and protected.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejp.1905DOI Listing

Publication Analysis

Top Keywords

systematic reviews
24
'gold standard'
8
standard' evidence
8
systematic
7
reviews
5
reviews represent
4
represent 'gold
4
evidence position
4
position paper
4
paper low
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!